Invega (Paliperidone) for the Treatment of Mania in Children and Adolescents Ages 6-17 With Bipolar Disorder
NCT00592358
·
clinicaltrials.gov ↗
PHASE4
Phase
TERMINATED
Status
17
Enrollment
OTHER
Sponsor class
Stopped
Slow enrollment.
Conditions
Pediatric Bipolar Disorder
Interventions
DRUG:
paliperidone
Sponsor
Massachusetts General Hospital